Green Journals

Year	A	B
2026	✓	✓
2025	✓	✓
2024	✓	✓
2023	✓	✓
2021/2022	✓	✓
2020	✓	✓
2019	✓	✓
2018	✓

Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors

Seyma Erdogan, Yusufcan Yılmaz, Elif Reyhan Aslan et al.

2026-11 Vol. 26 Issue 11 Pages 25-31

DOI: 10.1016/j.clbc.2026.09.009

Core Outcome Set Measures Are Underreported in Breast Cancer Randomized Clinical Trials: A Cross-Sectional Study

Alexander Douglas, Ty Moore, Griffin Hughes et al.

2026-11 Vol. 26 Issue 11 Pages 9-16

DOI: 10.1016/j.clbc.2026.09.003

Value of Breast and Axillary Tumor-Infiltrating Lymphocytes for Response to Neoadjuvant Chemo-(Immuno)Therapy in Clinically Node-Positive Breast Cancer

Melissa Lenaerts, Loes F.S. Kooreman, Florien J.G. van Amstel et al.

2026-11 Vol. 26 Issue 11 Pages 17-24

DOI: 10.1016/j.clbc.2026.09.007

Clinical Utility of [18F]Fluoroestradiol PET/CT to Guide Second Line Treatment Decision in ER-Positive HER2-Negative Metastatic Breast Cancer After Progression on First Line Endocrine Therapy

Hannah M. Linden, Sophia R. O’Brien, Stephanie M. van de Ven et al.

2026-11 Vol. 26 Issue 11 Pages 32-39

DOI: 10.1016/j.clbc.2026.09.008

Feasibility and Outcomes of Concomitant Boost in Prone Hypofractionated Whole-Breast Irradiation Using 3D-Conformal Radiotherapy

Pavnesh Kumar, Tanun Jitwatcharakomol, Jonathan E. Schoenhals et al.

2026-11 Vol. 26 Issue 11 Pages 66-73

DOI: 10.1016/j.clbc.2026.09.012

Ketamine Versus Magnesium Sulphate as Adjuvants to Bupivacaine in Pectoral Nerve Blocks for Mastectomy: A Randomized, Double-Blind Trial

Doaa Moaz Sayem, Ahmed Abdelaziz Shama, Mohamed Ali Mahmoud et al.

2026-11 Vol. 26 Issue 11 Pages 40-47

DOI: 10.1016/j.clbc.2026.09.010

Early On-Treatment Ultrasound Tumor Shrinkage and HER2-Positive Residual Invasive Disease After Neoadjuvant Therapy: A 2-Center Study

Chi Zhang, Lin Zhou, Lingfeng Tang et al.

2026-11 Vol. 26 Issue 11 Pages 48-57

DOI: 10.1016/j.clbc.2026.09.006

Incidence and Treatment Patterns of Pleomorphic Lobular Carcinoma in Situ: A Population-based Analysis After the Introduction of ICD-O-3 Code 8519/2

İsmail Zihni, Mehmet Zafer Sabuncuoğlu

2026-11 Vol. 26 Issue 11 Pages 1-8

DOI: 10.1016/j.clbc.2026.09.001

Cancer in Young Women: Late-Stage Breast Cancer Registry Analysis of a 24-Year Nationwide Retrospective Cohort of 52,734 Patients in Brazil (CLARA Study)

Ana Carolina Pires, Anke Bergmann, Cristiano Resende et al.

2026-10 Vol. 26 Issue 10 Pages 129-133

DOI: 10.1016/j.clbc.2026.08.007

Clinical Outcomes and Chemoprevention in High-Risk Breast Lesions: A Comparison of Atypical Ductal Hyperplasia and Lobular Carcinoma In Situ

Ye Ryung Kim, Mi Young Jang, Jai Hyun Chung et al.

2026-10 Vol. 26 Issue 10 Pages 169-174

DOI: 10.1016/j.clbc.2026.08.020

Journal Report

Journal Information

Classification History

Recent Articles